315 related articles for article (PubMed ID: 14724246)
1. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase.
Giri S; Nath N; Smith B; Viollet B; Singh AK; Singh I
J Neurosci; 2004 Jan; 24(2):479-87. PubMed ID: 14724246
[TBL] [Abstract][Full Text] [Related]
2. Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells.
Hattori Y; Suzuki K; Hattori S; Kasai K
Hypertension; 2006 Jun; 47(6):1183-8. PubMed ID: 16636195
[TBL] [Abstract][Full Text] [Related]
3. AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) increases the production of toxic molecules and affects the profile of cytokines release in LPS-stimulated rat primary microglial cultures.
Łabuzek K; Liber S; Gabryel B; Okopień B
Neurotoxicology; 2010 Jan; 31(1):134-46. PubMed ID: 19853624
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase and cyclooxygenase-2 gene expression by 5-aminoimidazole-4-carboxamide riboside is independent of AMP-activated protein kinase.
Kuo CL; Ho FM; Chang MY; Prakash E; Lin WW
J Cell Biochem; 2008 Feb; 103(3):931-40. PubMed ID: 17615555
[TBL] [Abstract][Full Text] [Related]
5. 5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages.
Jhun BS; Jin Q; Oh YT; Kim SS; Kong Y; Cho YH; Ha J; Baik HH; Kang I
Biochem Biophys Res Commun; 2004 May; 318(2):372-80. PubMed ID: 15120611
[TBL] [Abstract][Full Text] [Related]
6. Activation of AMPK inhibits inflammation in MRL/lpr mouse mesangial cells.
Peairs A; Radjavi A; Davis S; Li L; Ahmed A; Giri S; Reilly CM
Clin Exp Immunol; 2009 Jun; 156(3):542-51. PubMed ID: 19438609
[TBL] [Abstract][Full Text] [Related]
7. Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle.
Li J; Hu X; Selvakumar P; Russell RR; Cushman SW; Holman GD; Young LH
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E834-41. PubMed ID: 15265762
[TBL] [Abstract][Full Text] [Related]
8. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation.
Nagata D; Takeda R; Sata M; Satonaka H; Suzuki E; Nagano T; Hirata Y
Circulation; 2004 Jul; 110(4):444-51. PubMed ID: 15262850
[TBL] [Abstract][Full Text] [Related]
9. Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells.
Morrow VA; Foufelle F; Connell JM; Petrie JR; Gould GW; Salt IP
J Biol Chem; 2003 Aug; 278(34):31629-39. PubMed ID: 12791703
[TBL] [Abstract][Full Text] [Related]
10. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase.
Rattan R; Giri S; Singh AK; Singh I
J Biol Chem; 2005 Nov; 280(47):39582-93. PubMed ID: 16176927
[TBL] [Abstract][Full Text] [Related]
11. 5-aminoimidazole-4-carboxamide-1-beta-ribofuranoside (AICAR) prevents nuclear translocation of constitutive androstane receptor by AMP-activated protein kinase (AMPK) independent manner.
Kanno Y; Inoue Y; Inouye Y
J Toxicol Sci; 2010 Aug; 35(4):571-6. PubMed ID: 20686344
[TBL] [Abstract][Full Text] [Related]
12. 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes.
Salt IP; Connell JM; Gould GW
Diabetes; 2000 Oct; 49(10):1649-56. PubMed ID: 11016448
[TBL] [Abstract][Full Text] [Related]
13. 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside stimulates tyrosine hydroxylase activity and catecholamine secretion by activation of AMP-activated protein kinase in PC12 cells.
Fukuda T; Ishii K; Nanmoku T; Isobe K; Kawakami Y; Takekoshi K
J Neuroendocrinol; 2007 Aug; 19(8):621-31. PubMed ID: 17620104
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of glucokinase translocation by AMP-activated protein kinase is associated with phosphorylation of both GKRP and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.
Mukhtar MH; Payne VA; Arden C; Harbottle A; Khan S; Lange AJ; Agius L
Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R766-74. PubMed ID: 18199594
[TBL] [Abstract][Full Text] [Related]
15. Effects of stimulation of AMP-activated protein kinase on insulin-like growth factor 1- and epidermal growth factor-dependent extracellular signal-regulated kinase pathway.
Kim J; Yoon MY; Choi SL; Kang I; Kim SS; Kim YS; Choi YK; Ha J
J Biol Chem; 2001 Jun; 276(22):19102-10. PubMed ID: 11262401
[TBL] [Abstract][Full Text] [Related]
16. Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside in the muscle microcirculation increases nitric oxide synthesis and microvascular perfusion.
Bradley EA; Eringa EC; Stehouwer CD; Korstjens I; van Nieuw Amerongen GP; Musters R; Sipkema P; Clark MG; Rattigan S
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1137-42. PubMed ID: 20224051
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hepatic phosphatidylcholine synthesis by 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside is independent of AMP-activated protein kinase activation.
Jacobs RL; Lingrell S; Dyck JRB; Vance DE
J Biol Chem; 2007 Feb; 282(7):4516-4523. PubMed ID: 17179149
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of insulin-stimulated glycogen synthesis by 5-aminoimidasole-4-carboxamide-1-beta-d-ribofuranoside-induced adenosine 5'-monophosphate-activated protein kinase activation: interactions with Akt, glycogen synthase kinase 3-3alpha/beta, and glycogen synthase in isolated rat soleus muscle.
Fediuc S; Gaidhu MP; Ceddia RB
Endocrinology; 2006 Nov; 147(11):5170-7. PubMed ID: 16873531
[TBL] [Abstract][Full Text] [Related]
19. Kinase-independent transcriptional co-activation of peroxisome proliferator-activated receptor alpha by AMP-activated protein kinase.
Bronner M; Hertz R; Bar-Tana J
Biochem J; 2004 Dec; 384(Pt 2):295-305. PubMed ID: 15312046
[TBL] [Abstract][Full Text] [Related]
20. AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress.
Terai K; Hiramoto Y; Masaki M; Sugiyama S; Kuroda T; Hori M; Kawase I; Hirota H
Mol Cell Biol; 2005 Nov; 25(21):9554-75. PubMed ID: 16227605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
